The effect of carnitine on patients receiving hemodialysis

The effect of carnitine on patients receiving hemodialysis - The effect of carnitine on patients receiving hemodialysis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007677

Enrollment

Registered

2012-04-09

Start date

2012-04-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis patients claiming muscle relating complaint

Interventions

administration 900mg of carnitine for 3 months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: hemodialysis patients claiming muscle symptom

Exclusion criteria

Exclusion criteria: allergic reaction with carnitine

Design outcomes

Primary

Measure	Time frame
Improvement of clinical symptom	—

Secondary

Measure	Time frame
serum carnitine concentration	—

Countries

Japan

Contacts

Public ContactYoshihiko KANNO

School of Medicine, Keio University Apheresis and Dialysis Center

kannoyh@tokyo-med.ac.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026